Aile Hekimliğinde Oral Ülserlere Yaklaşım

1. Scully C, Shotts R. ABC of oral health: mouth ulcers and other causes of orofacial soreness and pain. BMJ 2000; 321: 162-5.
2. Mcbride DR. Management of aphthous ulcers. Am Fam Physician 2000; 62: 149-54, 160.
3. Disorders of the oral region. The Merck Manual'de. Ed. Beers MH, Berkow R.17.Baskı. England, Merck & Co., 1999; 751-9.
4. McCarty MA, Garton RA, Jorizzo JL. Complex aphthosis and Behcet's disease. Dermatol Clin 2003; 21(1): 41-8.
5. Ghate JV, Jorizzo JL. Behçet's disease and complex aphthosis. J Am Acad Dermatol 1999; 40: 1-18.
6. Porter SR, Hegarty A, Kaliakatsou F, Hodgson TA, Scully C. Recur¬rent aphthous stomatitis. Clin Dermatol 2000; 18(5): 569-78.
7.
Tüzü
n Y, Tüzün B, Enver Ö. Dudak ve Ağız Boşluğu Hastalıkları.Der-matoloji'de. Ed. Tüzün Y, Kotogyan A, Aydemir EH, Baransü O. İstanbul, Nobel Tıp Kitabevleri, 1994; 537-54.
8. Pizarro A, Herranz P, de Lucas R, Borbujo J, Casado M. Pentoxifyl-line in recurrent aphthous stomatitis. J Am Acad Dermatol 1997; 36: 284.
9. Sun A, Chia JS, Chang YF, Chiang CP. Levamisole and Chinese me¬dicinal herbs can modulate the serum interleukin-6 level in patients with recurrent aphthous ulcerations. J Oral Pathol Med 2003; 32(4): 206-14.
10. Disorders of mucous membranes. Ed. Odoms RB, James WD, Berger TG . Andrews' Disease of the Skin'de. 9. baskı. Philadelphia, WB Saun-
ders company, 2000: 991-1010.
11. Yurdakul S, Tüzün Y, Mat MC, Özyazgan Y, Yazıcı H. Behçet send-romu. Dermatoloji'de. Ed. Tüzün Y, Kotogyan A, Aydemir EH, Baransü O. İstanbul, Nobel Tıp Kitabevleri, 1994: 393-9.
12. Jorizzo JL. Behçet's disease.Dermatology in General Medicine'de. Eds. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB. New York, McGraw-Hill, 1999: 2161-5.
13. International study group of Behçet's disease: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078.
14. Alpsoy E, Er H, Durusoy C, Yilmaz E. The use of sucralfate suspensi¬on in the treatment of oral and genital ulceration of Behcet disease: a ran¬domized, placebo-controlled, double-blind study. Arch Dermatol 1999;
135(5): 529-32.
15. lpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O, Yazar S, Basa-
ran E. Interferon alfa-2a in the treatment of Behcet disease: a randomi¬zed placebo-controlled and double-blind study. Arch Dermatol 2002;
138(4): 467-71.
16. Lichen planus and related conditions. Andrews'Diseases of the Skin'de. Ed. Odoms RB, James WD, Berger TG. 9. baskı. Philadelphia, WB Saunders company, 2000: 266- 83.
17. Lazaro P, Olalquiaga J, Bartolome J ve ark. Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C. J Invest Dermatol 2002; 119(4):
798-803.
18. Erkek E, Bozdogan O, Olut AI. Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol 2001; 26(6): 540-4.
19. Kirtak N, Inaloz HS, Ozgoztasi, Erbagci Z. The prevalence of hepati¬tis C virus infection in patients with lichen planus in Gaziantep region of Turkey. Eur J Epidemiol 2000; 16(12): 1159-61.
20. Gürer MA. Liken planus ve likenoid erupsiyonlar. Dermatoloji'de. Ed. Tüzün Y, Kotogyan A,Aydemir EH, Baransü O. Istanbul, Nobel Tıp Ki-
tabevleri, 1994: 339-45.
21. Daoud MS, Pittelkow MR. Lichen planus. Dermatology in General Me-dicine'de. Ed. Freedberg IM, Eisen AZ, Wolff K ve ark. New York,
McGraw-Hill, 1999: 561-77.
22. Tüzün Y, Mat MC. Büllü hastalıklar. Dermatoloji'de. Eds. Tüzün Y, Kotogyan A,Aydemir EH, Baransü O. Istanbul, Nobel Tıp Kitabevleri,
1994: 353-77.
Türkiye Aile Hekimliği Dergisi |
Turkish Journal of Family Practice | Cilt 7 | Sayı 4 | 2003 | 175
23. Chronic blistering dermatoses.Andrews'Didease of the Skin'de. Eds. Odoms RB, James WD, Berger TG. 9.Baskı. Philadelphia, WB Saunders
company, 2000: 574-605.
24. Stanley JR. Pemphigus and Pemphigoid. Dermatology in General Medi-cine'de. Eds. Freedberg IM, Eisen AZ, Wolff K ve ark. New York,
McGraw-Hill, 1999: 654-73.
25. Schaerer L, Trueb RM. Direct immunofluoroscence of plucked hair in
pemphigus. Arch Dermatol 2003; 139(2): 228-9.
26. Palleschi GM, Cipollini EM, Lotti T. Development of oesophageal in¬volvement in a subject with pemphigus vulgaris: a case report and review of the literature. J Eur Acad Dermatol Venereol 2002; 16(4): 405-8.
27. Femiano F, Gombos F, Scully C. Pemphigus vulgaris with oral involve¬ment: evaluation of two different systemic corticosteroid therapeutic pro¬tocols. J Eur Acad Dermatol Venereol 2002; 16(4): 353-6.
28. Sami N, Qureshi A, Ruocco E, Ahmed AR. Corticosteroid-sparing ef¬fect of intravenous immunoglobulin therapy in patients with pemphigus
vulgaris. Arch Dermatol 2002; 138(9): 1158-62.
176 |
Yıldırım M, Aydın S | Aile Hekimliğinde Oral Ülserlere Yaklaşım
29. Toth GG, van de Meer JB, Jonkman MF. Dexamethasone pulse the¬rapy in pemphigus. J Eur Acad Dermatol Venereol 2002; 16(6): 607-11.
30. Mazzi G, Raineri A, Zanolli FA ve ark. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid. Transfus Apheresis Sci
2003; 28(1): 13-8.
31. Bystryn JC, Jiao D, Natow S. Treatment of pemphigus with intraveno¬us immunoglobulin. J Am Acad Dermatol 2002; 47(3): 358-63.
32. Karpouzis A, Vamvassakis E, Stavrianeas N, Koumantaki-Mathiou-daki E, Karpouzi M, Vareltzides A. Ultrastructural immunocytoche-mistry of autoimmune bullous diseases. Australas J Dermatol 2002;
43(2): 113-9.
33. Hatano Y, Katagiri K, Arakawa S, Umeki T, Takayasu S, Fujiwara
S. Successful treatment by double-filtration plasmapheresis of a patient with bullous pemphigoid: effects in vivo on transcripts of several genes for chemokines and cytokines in peripheral blood mononuclear cells. Br J Dermatol 2003; 148(3): 573-9.